Illuminating and Treating Diseases
Nuclear medicine involves the use of small amounts of radioactive materials (or tracers) to help diagnose and treat a variety of diseases. Nuclear medicine determines the cause of the medical problem based on the function of the organ, tissue or bone. This is how nuclear medicine differs from an x-ray, ultrasound or any other diagnostic test that determines the presence of disease based on structural appearance. More
SNMMI Designates First Radiopharmaceutical Therapy Centers of Excellence
March 2022
"The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the Dana-Farber Brigham Cancer Center as its first two designated Radiopharmaceutical Therapy Centers of Excellence. The institutions are designated as comprehensive centers that administer multiple radiopharmaceutical therapies — such as those to treat thyroid cancer, prostate cancer and neuroendocrine tumors—and activelyengage in radiopharmaceutical therapy research. SNMMI created the Radiopharmaceutical Therapy Center of Excellence program to certify sites that meet strict regulatory, training, qualification, experience and performance criteria for radiopharmaceutical therapy. With the Radiopharmaceutical Therapy Centers of Excellence designation, institutions can assure patients, their families, referring physicians and payors that rigorous procedures are in place and followed, ultimately leading to appropriate patient selection and optimal outcomes from radiopharmaceutical therapy." |
Molecular Imaging: Principles and Practice, 2nd Edition
August 2021
On August 9th, 2021, the textbook Molecular Imaging: Principles and Practice, 2nd Edition, (Volumes 1 & 2) was published. This textbook was edited by Sanjiv Sam Gambhir, MD, PhD, and Brian Ross, PhD with contributions from Dr. Andrei Iagaru, Dr. Craig Levin & Dr. Farshad Moradi.
The detection and measurement of the dynamic regulation and interactions of cells and proteins within the living cell are critical to the understanding of cellular biology and pathophysiology. The multidisciplinary field of molecular imaging of living subjects continues to expand with dramatic advances in chemistry, molecular biology, therapeutics, engineering, medical physics and biomedical applications. Molecular Imaging: Principles and Practice, Volumes 1 and 2, Second Edition provides the first point of entry for physicians, scientists, and practitioners. This authoritative reference book provides a comprehensible overview along with in-depth presentation of molecular imaging concepts, technologies and applications making it the foremost source for both established and new investigators, collaborators, students and anyone interested in this exciting and important field.
Grand Opening of the Theragnostics Space in Nuclear Medicine
May 2021
The Division of Nuclear Medicine and Molecular Imaging held a ribbon cutting ceremony for the new Theragnostics space on May 13, 2021. This was a small gathering due to CoVID restrictions, but we were able to bring together colleagues and friends who contributed to the completion of this project. Many more watched the live streaming courtesy of Josh Mailman. It was an emotional evening as we recognized Dr McDougall's illustrious career, paid homage to Sam's vision and legacy and dedicated the newly opened area to Ross, Sam, the patients and their families.
We hope you will enjoy reading the brochure and watching the recording.
PET/MRI in Oncology
February 2018
In this book, experts from premier institutions across the world with extensive experience in the field clearly and succinctly describe the current and anticipated uses of PET/MRI in oncology. The book also includes detailed presentations of the MRI and PET technologies as they apply to the combined PET/MRI scanners. The applications of PET/MRI in a wide range of oncological settings are well documented, highlighting characteristic findings, advantages of this dual-modality technique, and pitfalls. Whole-body PET/MRI applications and pediatric oncology are discussed separately. In addition, information is provided on PET technology designs and MR hardware for PET/MRI, MR pulse sequences and contrast agents, attenuation and motion correction, the reliability of standardized uptake value measurements, and safety considerations. The balanced presentation of clinical topics and technical aspects will ensure that the book is of wide appeal. It will serve as a reference for specialists in nuclear medicine and radiology and oncologists and will also be of interest for residents in these fields and technologists.
FDG: Forty Years of Changing Lives
Theragnostics Ribbon Cutting Ceremony
News
.jpg)
Staff Transition
December 2021
Paulo Castaneda, MBA, CNMT, ARRT(N), was appointed as the Imaging Director at Stanford Health Care effective December 15, 2021. Mr. Castaneda joined Stanford in 2007 as a Nuclear Medicine and PET-CT technologist, with promotions to Lead Technologist in 2013, Nuclear Medicine Supervisor in 2015 and Manager of Nuclear Medicine in 2017. He was instrumental in the successful opening of Imaging at the Cancer Center South Bay location. Most recently the Theragnostic Clinic in Nuclear Medicine opened to patient care under his leadership. He has also participated in many process improvement initiatives including completing RITE and CELT projects. Among his many accolades is the recognition as Stanford Health Care Award for Special Contribution 2017 and Stanford Radiology Employee of the Year 2020. Mr. Castaneda graduated from UCLA with a Bachelor of Science in Biology in 2002. He graduated from the VA Nuclear Medicine Training program in 2007 and completed a Master of Business Administration from Western Governors University in 2021. He will serve as one of the Imaging Directors providing guidance and direction for managers and clinical sites as well as project leadership. Congratulations Paulo! |
Society of Nuclear Medicine and Molecular Imaging "Ones to Watch" 2021
July 2021
Hong Song was recognized on SNMMI's annual list of 30 early career professionals selected as "Ones to Watch" in 2021. Launched in 2018, SNMMI’s Ones to Watch campaign aims to recognize those with the potential to shape the future of precision medicine across all spectrums of the field. Congratulations Hong on this well deserved recognition!
Society of Nuclear Medicine and Molecular Imaging Technologist Section
March 2021
Kim Ramos was awarded 3rd Place Technologist PET Oral Abstract at the SNMMI Virtual Annual Meeting. Congratulations Kim!
Staff of the Year Award
February 2021
Congratulations to Sarina Smith who received the Staff of the Year Award! This is well-deserved recognition for the wonderful job Sarina is doing in all aspects of her work. Whole-hearted thank you from the entire Division of Nuclear Medicine and Molecular Imaging.
American College of Nuclear Medicine (ACNM) Board of Directors
January 2021
The American College of Nuclear Medicine (ACNM) elected Carina Mari Aparici to the ACNM Board of Directors. Congratulations Carina!
PhD Award for Best ACNM Nuclear Medicine Research Abstract
January 2021
Heying Duan was recognized at the American College of Nuclear Medicine (ACNM) Mid Winter Meeting for her research abstract, "Peptide Receptor Radionuclide Therapy (PRRT) in Non-Midgut Neuroendocrine Tumors (NETs) from a Single Institution Experience". Congratulations Heying!
Technologist of the Year Award
Employee of the Year Award
January 2021
Congratulations to Luan Nguyen who received the Technologist of the Year Award and Paulo Castaneda who received Employee of the Year from the entire Department of Radiology at Stanford! Go Nucs!